Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Longboard Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
11/17/2021 |
3
| Tiller Jane (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| ARENA PHARMACEUTICALS INC (10% Owner) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Le Goff Corinne (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Lynch Casey (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| SEKHRI PAUL J (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| SCHNEIDER PHILLIP M (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Aurentz Vincent (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Roberts Brandi (CFO) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Perera Philip (Chief Medical Officer) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Lind Kevin Robert (President and CEO) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
|
|